Brian D. Bradbury, Sc.D. - Publications

Affiliations: 
2004 Boston University, Boston, MA, United States 
Area:
Public Health

9/103 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Muntner P, Hernandez RK, Kent ST, Browning JE, Gilbertson DT, Hurwitz KE, Jick SS, Lai EC, Lash TL, Monda KL, Rothman KJ, Bradbury BD, Brookhart MA. Staging and clean room: Constructs designed to facilitate transparency and reduce bias in comparative analyses of real-world data. Pharmacoepidemiology and Drug Safety. 33: e5770. PMID 38419140 DOI: 10.1002/pds.5770  0.544
2023 Levintow SN, Nielson CM, Hernandez RK, Breskin A, Pritchard D, Lash TL, Rothman KJ, Gilbertson D, Muntner P, Critchlow C, Brookhart MA, Bradbury BD. Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: A narrative review. Pharmacoepidemiology and Drug Safety. PMID 36965103 DOI: 10.1002/pds.5623  0.551
2022 Hernandez RK, Nakasian SS, Bollinger L, Bradbury BD, Jick SS, Muntner P, Ng E, Chia V. Changes in Medication Use During Pregnancy for Women with Chronic Conditions: An Analysis of Claims Data. Therapeutic Innovation & Regulatory Science. PMID 36562933 DOI: 10.1007/s43441-022-00489-8  0.564
2006 Bradbury BD, Lash TL, Kaye JA, Jick SS. Author reply [2] Cancer. 106: 481. DOI: 10.1002/cncr.21585  0.336
2005 Bradbury BD, Lash TL, Kaye JA, Jick SS. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Cancer. 103: 1114-21. PMID 15712362 DOI: 10.1002/Cncr.20900  0.505
2004 Bradbury BD, Lash TL, Kaye JA, Jick SS. Tamoxifen and cataracts: a null association. Breast Cancer Research and Treatment. 87: 189-96. PMID 15377843 DOI: 10.1023/B:Brea.0000041626.76694.85  0.507
2004 Jick SS, Bradbury BD. Statins and newly diagnosed diabetes. British Journal of Clinical Pharmacology. 58: 303-9. PMID 15327590 DOI: 10.1111/J.1365-2125.2004.02142.X  0.494
2003 Kaye JA, Bradbury BD, Jick H. Changes in antipsychotic drug prescribing by general practitioners in the United Kingdom from 1991 to 2000: a population-based observational study. British Journal of Clinical Pharmacology. 56: 569-75. PMID 14651732 DOI: 10.1046/J.1365-2125.2003.01905.X  0.339
2002 Bradbury BD, Jick SS. Itraconazole and fluconazole and certain rare, serious adverse events. Pharmacotherapy. 22: 697-700. PMID 12066960 DOI: 10.1592/Phco.22.9.697.34072  0.453
Low-probability matches (unlikely to be authored by this person)
2005 Lash TL, Bradbury BD, Wilk JB, Aschengrau A. A case-only analysis of the interaction between N-acetyltransferase 2 haplotypes and tobacco smoke in breast cancer etiology. Breast Cancer Research : Bcr. 7: R385-93. PMID 15987434 DOI: 10.1186/Bcr1013  0.287
2005 Bradbury BD, Brooks DR, Brawarsky P, Mucci LA. Test-retest reliability of colorectal testing questions on the Massachusetts Behavioral Risk Factor Surveillance System (BRFSS). Preventive Medicine. 41: 303-11. PMID 15917026 DOI: 10.1016/J.Ypmed.2004.11.015  0.263
2005 Bradbury BD, Wilk JB, Kaye JA. Obesity and the risk of prostate cancer (United States). Cancer Causes & Control : Ccc. 16: 637-41. PMID 16049801 DOI: 10.1007/S10552-005-0383-6  0.26
2012 Bradbury BD, Gilbertson DT, Brookhart MA, Kilpatrick RD. Confounding and control of confounding in nonexperimental studies of medications in patients with CKD. Advances in Chronic Kidney Disease. 19: 19-26. PMID 22364797 DOI: 10.1053/J.Ackd.2012.01.001  0.256
2023 Kim M, Lin TC, Arora T, Zhao H, Balasubramanian A, Stad RK, O'Kelly J, Spangler L, Bradbury BD, Curtis JR. Comparability of Osteoporosis Treatment Groups Among Female Medicare Beneficiaries in the United States. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 37088886 DOI: 10.1002/jbmr.4817  0.241
2009 Bradbury BD, Brookhart MA, Winkelmayer WC, Critchlow CW, Kilpatrick RD, Joffe MM, Feldman HI, Acquavella JF, Wang O, Rothman KJ. Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 54: 554-60. PMID 19592144 DOI: 10.1053/J.Ajkd.2009.05.010  0.219
2015 Gilbertson DT, Bradbury BD, Wetmore JB, Weinhandl ED, Monda KL, Liu J, Brookhart MA, Gustafson SK, Roberts T, Collins AJ, Rothman KJ. Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders. Pharmacoepidemiology and Drug Safety. PMID 26608680 DOI: 10.1002/Pds.3922  0.207
2024 Barberio J, Naimi AI, Patzer RE, Kim C, Hernandez RK, Brookhart MA, Gilbertson D, Bradbury BD, Lash TL. Influence of Incomplete Death Information on Cumulative Risk Estimates in United States Claims Data. American Journal of Epidemiology. PMID 38583932 DOI: 10.1093/aje/kwae034  0.201
2020 McGrath LJ, Spangler L, Curtis JR, Ehrenstein V, Sørensen HT, Saul B, Levintow SN, Reams D, Bradbury BD, Brookhart MA. Using negative control outcomes to assess the comparability of treatment groups among women with osteoporosis in the United States. Pharmacoepidemiology and Drug Safety. PMID 32537883 DOI: 10.1002/Pds.5037  0.201
2005 BRADBURY B, HATCH E, ASCHENGRAU A, LASH T. CYP3A41B variant allele and the risk of breast cancer Annals of Epidemiology. 15: 635-635. DOI: 10.1016/J.Annepidem.2005.06.015  0.197
2004 Bradbury BD, Jick H. In vitro fertilization and childhood retinoblastoma. British Journal of Clinical Pharmacology. 58: 209-11. PMID 15255804 DOI: 10.1111/J.1365-2125.2004.02109.X  0.193
2006 Bradbury BD, Wilk JB, Aschengrau A, Lash TL. Departure from multiplicative interaction for catechol-O-methyltransferase genotype and active/passive exposure to tobacco smoke among women with breast cancer. Journal of Carcinogenesis. 5: 3. PMID 16417624 DOI: 10.1186/1477-3163-5-3  0.192
2017 Mues KE, Liede A, Liu J, Wetmore JB, Zaha R, Bradbury BD, Collins AJ, Gilbertson DT. Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US. Clinical Epidemiology. 9: 267-277. PMID 28533698 DOI: 10.2147/CLEP.S105613  0.183
2019 Li S, Liu J, Gong T, Guo H, Gawade PL, Kelsh MA, Bradbury BD, Belani R, Lyman GH. Risk of neutropenia-related hospitalization (NRH) related to duration of short-acting granulocyte colony stimulating factor (sG-CSF) for primary prophylaxis. Journal of Clinical Oncology. 37: e18181-e18181. DOI: 10.1200/JCO.2019.37.15_SUPPL.E18181  0.182
2017 Bratton E, Inomata H, Bradbury B, Kim D, Monda K, Arai H. P766Evaluation of statin users, people with hypercholesterolemia, and cardiovascular disease patients in the Japan Medical Data Center claims database European Heart Journal. 38. DOI: 10.1093/Eurheartj/Ehx501.P766  0.18
2016 Kim D, Peng Y, Li S, Hardin J, Beaubrun A, Mues K, Bradbury B, Monda K, Muntner P, Rosenson R, Herzog C. UNDERUTILIZATION OF STATIN THERAPY AFTER A CARDIOVASCULAR EVENT OR DIABETES DIAGNOSIS IN THREE REAL-WORLD DATA SYSTEMS Journal of the American College of Cardiology. 67: 1977. DOI: 10.1016/S0735-1097(16)31978-7  0.179
2008 Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Rothman KJ, Fischer M, Mehta J, Winkelmayer WC. The effect of altitude on dosing and response to erythropoietin in ESRD. Journal of the American Society of Nephrology : Jasn. 19: 1389-95. PMID 18385423 DOI: 10.1681/Asn.2007111181  0.176
2021 Liu J, Guo H, Lin TC, Wetmore JB, Bradbury BD, Gilbertson DT, Nieman K, Peng Y, Sprafka JM, Dluzniewski PJ. Cinacalcet and Gastrointestinal Bleeding Risk in Patients Receiving Hemodialysis. Pharmacoepidemiology and Drug Safety. PMID 34363294 DOI: 10.1002/pds.5337  0.172
2008 Gilbertson DT, Roberts T, Arneson T, Dunning S, Collins A, Bradbury B. 89: Identification of Patients with CKD Using Medicare Data: Inpatient vs. Outpatient Claims American Journal of Kidney Diseases. 51: B50. DOI: 10.1053/j.ajkd.2008.02.095  0.168
2011 Brookhart MA, Bradbury BD, Avorn J, Schneeweiss S, Winkelmayer WC. The effect of altitude change on anemia treatment response in hemodialysis patients. American Journal of Epidemiology. 173: 768-77. PMID 21345929 DOI: 10.1093/Aje/Kwq423  0.163
2013 Bowling CB, Muntner P, Bradbury BD, Kilpatrick RD, Isitt JJ, Warriner AH, Curtis JR, Judd S, Brown CJ, Allman RM, Warnock DG, McClellan W. Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort. The American Journal of the Medical Sciences. 345: 446-54. PMID 23328832 DOI: 10.1097/Maj.0B013E3182638364  0.162
2015 Reams BD, Dluzniewski PJ, Do TP, Yue SV, Bradbury BD, Kshirsagar AV, Brookhart MA. Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design. Bmc Nephrology. 16: 175. PMID 26510587 DOI: 10.1186/S12882-015-0174-6  0.156
2016 Chertow GM, Liu J, Monda KL, Gilbertson DT, Brookhart MA, Beaubrun AC, Winkelmayer WC, Pollock A, Herzog CA, Ashfaq A, Sturmer T, Rothman KJ, Bradbury BD, Collins AJ. Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform. Journal of the American Society of Nephrology : Jasn. PMID 26917691 DOI: 10.1681/Asn.2015111232  0.154
2007 Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clinical Journal of the American Society of Nephrology : Cjasn. 2: 89-99. PMID 17699392 DOI: 10.2215/Cjn.01170905  0.146
2016 Brunelli SM, Sibbel S, Dluzniewski PJ, Cooper K, Bensink ME, Bradbury BD. The association between cinacalcet use and missed in-center hemodialysis treatment rate. Pharmacoepidemiology and Drug Safety. PMID 27346298 DOI: 10.1002/pds.4050  0.145
2013 Brunelli SM, Monda KL, Burkart JM, Gitlin M, Neumann PJ, Park GS, Symonian-Silver M, Yue S, Bradbury BD, Rubin RJ. Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 61: 947-56. PMID 23332991 DOI: 10.1053/J.Ajkd.2012.11.040  0.141
2008 Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF. Exploring relative mortality and epoetin alfa dose among hemodialysis patients. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 51: 62-70. PMID 18155534 DOI: 10.1053/J.Ajkd.2007.09.015  0.14
2010 Seliger S, Fox KM, Gandra SR, Bradbury B, Hsu VD, Walker L, Chiou CF, Fink JC. Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 882-8. PMID 20299377 DOI: 10.2215/Cjn.07171009  0.139
2015 St Peter WL, Yusuf AA, Do T, Lowe KA, Liu J, Nieman KM, Bradbury BD, Collins AJ. Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study. Bmc Nephrology. 16: 41. PMID 25886282 DOI: 10.1186/s12882-015-0030-8  0.138
2014 Collins AJ, Monda KL, Molony JT, Li S, Gilbertson DT, Bradbury BD. Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 63: 997-1006. PMID 24315770 DOI: 10.1053/J.Ajkd.2013.10.052  0.135
2016 Block GA, Yusuf AA, Danese MD, Wirtz HS, Hu Y, Do TP, Cooper K, Gilbertson DT, Bradbury BD, Collins AJ. Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis. Bmc Nephrology. 17: 166. PMID 27814753 DOI: 10.1186/s12882-016-0382-8  0.133
2022 Schenfeld J, Gong T, Henry D, Kelsh M, Gawade P, Peng Y, Bradbury BD, Li S. Patterns of primary prophylactic granulocyte colony-stimulating factor use in older Medicare patients with cancer receiving myelosuppressive chemotherapy. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 35482126 DOI: 10.1007/s00520-022-06967-x  0.133
2011 Regidor D, McClellan WM, Kewalramani R, Sharma A, Bradbury BD. Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 1583-91. PMID 20861195 DOI: 10.1093/ndt/gfq573  0.133
2019 Desai RJ, Kim SC, Curtis JR, Bosco JLF, Eichelberger B, Barr CE, Lockhart CM, Bradbury BD, Clewell J, Cohen HP, Gagne JJ. Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars. Pharmacoepidemiology and Drug Safety. PMID 31298463 DOI: 10.1002/pds.4809  0.132
2021 Storm NE, Chang W, Lin TC, Lange JL, Bradbury B, Critchlow CW, Galson SK. A Novel Case Study of the Use of Real-World Evidence to Support the Registration of an Osteoporosis Product in China. Therapeutic Innovation & Regulatory Science. PMID 34633649 DOI: 10.1007/s43441-021-00342-4  0.131
2014 Liu J, Li S, Gilbertson DT, Monda KL, Bradbury BD, Collins AJ. Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 64: 608-15. PMID 24820317 DOI: 10.1053/J.Ajkd.2014.04.012  0.13
2015 Ishani A, Liu J, Wetmore JB, Lowe KA, Do T, Bradbury BD, Block GA, Collins AJ. Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis. Clinical Journal of the American Society of Nephrology : Cjasn. 10: 90-7. PMID 25516915 DOI: 10.2215/CJN.03520414  0.128
2014 Robinson BM, Zhang J, Morgenstern H, Bradbury BD, Ng LJ, McCullough KP, Gillespie BW, Hakim R, Rayner H, Fort J, Akizawa T, Tentori F, Pisoni RL. Worldwide, mortality risk is high soon after initiation of hemodialysis Kidney International. 85: 158-165. PMID 23802192 DOI: 10.1038/Ki.2013.252  0.127
2022 Page JH, Londhe AA, Brooks C, Zhang J, Sprafka JM, Bennett C, Braunlin M, Brown CA, Charuworn P, Cheng A, Gill K, He F, Ma J, Petersen J, Ayodele O, ... ... Bradbury BD, et al. Trends in characteristics and outcomes among US adults hospitalised with COVID-19 throughout 2020: an observational cohort study. Bmj Open. 12: e055137. PMID 35228287 DOI: 10.1136/bmjopen-2021-055137  0.126
2009 Bradbury BD, Chen F, Furniss A, Pisoni RL, Keen M, Mapes D, Krishnan M. Conversion of vascular access type among incident hemodialysis patients: description and association with mortality. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 53: 804-14. PMID 19268411 DOI: 10.1053/j.ajkd.2008.11.031  0.125
2020 Fuller DS, Dluzniewski PJ, Cooper K, Bradbury BD, Robinson BM, Tentori F. Combinations of mineral and bone disorder markers and risk of death and hospitalizations in the international Dialysis Outcomes and Practice Patterns Study. Clinical Kidney Journal. 13: 1056-1062. PMID 33391749 DOI: 10.1093/ckj/sfz112  0.124
2013 Kilpatrick RD, Gilbertson D, Brookhart MA, Polley E, Rothman KJ, Bradbury BD. Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions. Pharmacoepidemiology and Drug Safety. 22: 111-21. PMID 22674782 DOI: 10.1002/Pds.3297  0.123
2012 McClellan WM, Warnock DG, Judd S, Muntner P, Patzer RE, Bradbury BD, McClure LA, Newsome BB, Howard G. Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 59: 25-31. PMID 22078058 DOI: 10.1053/J.Ajkd.2011.09.018  0.122
2015 Monda KL, Joseph PN, Neumann PJ, Bradbury BD, Rubin RJ. Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study. Bmc Nephrology. 16: 67. PMID 25928734 DOI: 10.1186/S12882-015-0059-8  0.121
2015 Wetmore JB, Liu J, Do TP, Lowe KA, Ishani A, Bradbury BD, Block GA, Collins AJ. Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 26292694 DOI: 10.1093/ndt/gfv291  0.12
2007 Alexander M, Mohanty S, Bradbury B, Kewalramani R, Barlev A, Globe D. 3 American Journal of Kidney Diseases. 49: B25. DOI: 10.1053/j.ajkd.2007.02.007  0.12
2010 Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Liu J, Winkelmayer WC. Comparative mortality risk of anemia management practices in incident hemodialysis patients. Jama. 303: 857-64. PMID 20197532 DOI: 10.1001/Jama.2010.206  0.118
2009 Bradbury BD, Danese MD, Gleeson M, Critchlow CW. Effect of Epoetin alfa dose changes on hemoglobin and mortality in hemodialysis patients with hemoglobin levels persistently below 11 g/dL. Clinical Journal of the American Society of Nephrology : Cjasn. 4: 630-7. PMID 19261826 DOI: 10.2215/Cjn.03580708  0.117
2016 Mues K, Peng Y, Li S, Hardin J, Kim D, Beaubrun A, Bradbury B, Monda K, Muntner P, Rosenson R, Herzog C. STATIN USE AND TITRATION PATTERNS IN THE FIRST YEAR FOLLOWING A CARDIOVASCULAR EVENT IN MEDICARE BENEFICIARIES Journal of the American College of Cardiology. 67: 2002. DOI: 10.1016/S0735-1097(16)32003-4  0.117
2020 Li S, Liu J, Gong T, Guo H, Gawade PL, Kelsh MA, Bradbury BD, Belani R, Lyman GH. Duration of short-acting granulocyte colony-stimulating factor for primary prophylaxis and risk of neutropenia-related hospitalization in older patients with cancer. Journal of Geriatric Oncology. PMID 32624415 DOI: 10.1016/j.jgo.2020.06.018  0.116
2020 Gawade PL, Li S, Henry D, Smith N, Belani R, Kelsh MA, Bradbury BD. Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 31919669 DOI: 10.1007/s00520-020-05295-2  0.116
2017 Gawade PL, Berlin JA, Henry DH, Tomita D, Brooks BD, Franklin J, Bradbury BD, Critchlow CW. Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes. Pharmacoepidemiology and Drug Safety. PMID 28809079 DOI: 10.1002/pds.4293  0.115
2015 Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, Bradbury BD, Collins AJ, Gilbertson DT. Trends in Anemia Management Practices in Patients Receiving Hemodialysis and Peritoneal Dialysis: A Retrospective Cohort Analysis. American Journal of Nephrology. 41: 354-361. PMID 26107376 DOI: 10.1159/000431335  0.114
2008 Bradbury B, Do T, Rothman K, Critchlow C, Collins A, Brookhart M, Krishnan M, Acquavella J. 34: Adjustment for Exposure History and Important Confounders Markedly Attenuates Elevated Mortality Risk Associated with Epoetin Alfa (EPO) Dose American Journal of Kidney Diseases. 51: B36. DOI: 10.1053/J.Ajkd.2008.02.039  0.113
2013 Tanner RM, Gutiérrez OM, Judd S, McClellan W, Bowling CB, Bradbury BD, Safford MM, Cushman M, Warnock D, Muntner P. Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 61: 395-403. PMID 23228944 DOI: 10.1053/J.Ajkd.2012.10.018  0.112
2010 Lawler EV, Gagnon DR, Fink J, Seliger S, Fonda J, Do TP, Gaziano JM, Bradbury BD. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 25: 2237-44. PMID 20083469 DOI: 10.1093/Ndt/Gfp758  0.111
2013 Gill KS, Muntner P, Lafayette RA, Petersen J, Fink JC, Gilbertson DT, Bradbury BD. Red blood cell transfusion use in patients with chronic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 28: 1504-15. PMID 23389999 DOI: 10.1093/Ndt/Gfs580  0.111
2009 Collins AJ, Guo H, Gilbertson DT, Bradbury BD. Predictors of ESA use in the non-dialysis chronic kidney disease population with anemia. Nephron. Clinical Practice. 111: c141-8. PMID 19147996 DOI: 10.1159/000191207  0.11
2011 Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ. Hemoglobin variability and mortality: confounding by disease severity. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 57: 255-65. PMID 20801571 DOI: 10.1053/j.ajkd.2010.06.013  0.108
2009 Bradbury BD, Do TP, Winkelmayer WC, Critchlow CW, Brookhart MA. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Pharmacoepidemiology and Drug Safety. 18: 932-40. PMID 19572312 DOI: 10.1002/Pds.1799  0.108
2021 Zhu J, Wei Z, Suryavanshi M, Chen X, Xia Q, Jiang J, Ayodele O, Bradbury BD, Brooks C, Brown CA, Cheng A, Critchlow CW, Devercelli G, Gandhi V, Gondek K, et al. Characteristics and outcomes of hospitalised adults with COVID-19 in a Global Health Research Network: a cohort study. Bmj Open. 11: e051588. PMID 34362806 DOI: 10.1136/bmjopen-2021-051588  0.107
2010 Lawler EV, Bradbury BD, Fonda JR, Gaziano JM, Gagnon DR. Transfusion burden among patients with chronic kidney disease and anemia. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 667-72. PMID 20299366 DOI: 10.2215/Cjn.06020809  0.099
2015 Brunelli SM, Sibbel S, Do TP, Cooper K, Bradbury BD. Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 26015274 DOI: 10.1053/j.ajkd.2015.03.038  0.097
2015 Gill K, Fink JC, Gilbertson DT, Monda KL, Muntner P, Lafayette RA, Petersen J, Chertow GM, Bradbury BD. Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease. Pharmacoepidemiology and Drug Safety. 24: 654-62. PMID 25903095 DOI: 10.1002/Pds.3779  0.097
2011 Ng LJ, Chen F, Pisoni RL, Krishnan M, Mapes D, Keen M, Bradbury BD. Hospitalization risks related to vascular access type among incident US hemodialysis patients. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 26: 3659-66. PMID 21372255 DOI: 10.1093/ndt/gfr063  0.096
2008 Gilbertson DT, Ebben JP, Foley RN, Weinhandl ED, Bradbury BD, Collins AJ. Hemoglobin level variability: associations with mortality. Clinical Journal of the American Society of Nephrology : Cjasn. 3: 133-8. PMID 18045862 DOI: 10.2215/CJN.01610407  0.094
2019 Li S, Liu J, Dluzniewski PJ, Wetmore JB, Gilbertson DT, Bradbury BD. Association of hospital transfusion use and infection-related rehospitalizations among patients receiving hemodialysis: A retrospective cohort study. Hemodialysis International. International Symposium On Home Hemodialysis. PMID 31829528 DOI: 10.1111/Hdi.12809  0.094
2010 McClellan WM, Resnick B, Lei L, Bradbury BD, Sciarra A, Kewalramani R, Ouslander JG. Prevalence and severity of chronic kidney disease and anemia in the nursing home population. Journal of the American Medical Directors Association. 11: 33-41. PMID 20129213 DOI: 10.1016/J.Jamda.2009.07.003  0.094
2010 Kilpatrick R, Bradbury B, Gilbertson D, Brookhart M, Polley E, Rothman K. Using IPTW Marginal Structural Modeling to Balance Confounding by Indication Annals of Epidemiology. 20: 717. DOI: 10.1016/J.Annepidem.2010.07.075  0.093
2014 Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL. High rates of death and hospitalization follow bone fracture among hemodialysis patients Kidney International. 85: 166-173. PMID 23903367 DOI: 10.1038/Ki.2013.279  0.092
2016 Molony JT, Monda KL, Li S, Beaubrun AC, Gilbertson DT, Bradbury BD, Collins AJ. Effects of Epoetin Alfa Titration Practices, Implemented After Changes to Product Labeling, on Hemoglobin Levels, Transfusion Use, and Hospitalization Rates. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 26980607 DOI: 10.1053/J.Ajkd.2016.02.038  0.092
2015 Danese MD, Halperin M, Lowe KA, Bradbury BD, Do TP, Block GA. Refining the definition of clinically important mineral and bone disorder in hemodialysis patients. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 30: 1336-44. PMID 25817224 DOI: 10.1093/ndt/gfv034  0.091
2023 Sing CW, Lin TC, Bartholomew S, J SB, Bennett C, Beyene K, Bosco-Levy P, Bradbury BD, Chan AHY, Chandran M, Cooper C, de Ridder M, Y CD, Droz-Perroteau C, Ganesan G, et al. Global epidemiology of hip fractures: secular trends in incidence rate, post-fracture treatment, and all-cause mortality. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 37118993 DOI: 10.1002/jbmr.4821  0.091
2012 Freburger JK, Ng LJ, Bradbury BD, Kshirsagar AV, Brookhart MA. Changing patterns of anemia management in US hemodialysis patients. The American Journal of Medicine. 125: 906-14.e9. PMID 22938926 DOI: 10.1016/J.Amjmed.2012.03.011  0.088
2009 Alexander M, Bradbury BD, Kewalramani R, Barlev A, Mohanty SA, Globe D. Chronic kidney disease and US healthcare resource utilization in a nationally representative sample. American Journal of Nephrology. 29: 473-82. PMID 19039210 DOI: 10.1159/000178816  0.083
2010 Wang O, Kilpatrick RD, Critchlow CW, Ling X, Bradbury BD, Gilbertson DT, Collins AJ, Rothman KJ, Acquavella JF. Relationship between epoetin alfa dose and mortality: findings from a marginal structural model. Clinical Journal of the American Society of Nephrology : Cjasn. 5: 182-8. PMID 20019122 DOI: 10.2215/Cjn.03040509  0.079
2011 Kurella Tamura M, Muntner P, Wadley V, Cushman M, Zakai NA, Bradbury BD, Kissela B, Unverzagt F, Howard G, Warnock D, McClellan W. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 58: 756-63. PMID 21816528 DOI: 10.1053/J.Ajkd.2011.05.027  0.079
2014 Ishani A, Gilbertson DT, Kim D, Bradbury BD, Collins AJ. Predialysis care and dialysis outcomes in hemodialysis patients with a functioning fistula. American Journal of Nephrology. 39: 238-47. PMID 24643209 DOI: 10.1159/000358843  0.074
2019 Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB. Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population. Journal of the American Society of Nephrology : Jasn. PMID 30679380 DOI: 10.1681/Asn.2018060581  0.073
2014 Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL. The authors reply Kidney International. 86: 649. PMID 25168502 DOI: 10.1038/ki.2014.160  0.071
2008 Kilpatrick RD, Critchlow CW, Fishbane S, Besarab A, Stehman-Breen C, Krishnan M, Bradbury BD. Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients. Clinical Journal of the American Society of Nephrology : Cjasn. 3: 1077-83. PMID 18417744 DOI: 10.2215/Cjn.04601007  0.071
2013 Gilbertson DT, Monda KL, Bradbury BD, Collins AJ. RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 62: 919-28. PMID 23815986 DOI: 10.1053/J.Ajkd.2013.05.004  0.07
2014 Leffell MS, Kim D, Vega RM, Zachary AA, Petersen J, Hart JM, Rossert J, Bradbury BD. Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation. Transplantation. 97: 525-33. PMID 24300013 DOI: 10.1097/01.tp.0000437435.19980.8f  0.069
2016 Block G, Do TP, Collins AJ, Cooper KC, Bradbury BD. Co-trending of parathyroid hormone and phosphate in patients receiving hemodialysis. Clinical Nephrology. PMID 26784912 DOI: 10.5414/CN108629  0.069
2013 Beaubrun AC, Kilpatrick RD, Freburger JK, Bradbury BD, Wang L, Brookhart MA. Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients. Journal of the American Society of Nephrology : Jasn. 24: 1461-9. PMID 23744885 DOI: 10.1681/Asn.2012090916  0.068
2016 Wetmore JB, Liu J, Wirtz HS, Gilbertson DT, Cooper K, Nieman KM, Collins AJ, Bradbury BD. Geovariation in Fracture Risk among Patients Receiving Hemodialysis. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 27269611 DOI: 10.2215/CJN.11651115  0.066
2011 Hussein UT, Cernii A, Lee Y, Bradbury BD, Petersen J, Finkelstein FO. Anemia Management and Hemoglobin Variability in CKD Patients Not on Dialysis American Journal of Kidney Diseases. 57: B48. DOI: 10.1053/j.ajkd.2011.02.129  0.064
2009 Gilbertson DT, Peng Y, Bradbury B, Ebben JP, Collins AJ. Hemoglobin level variability: anemia management among variability groups. American Journal of Nephrology. 30: 491-8. PMID 19786739 DOI: 10.1159/000243565  0.064
2009 Bradbury BD, Critchlow CW, Weir MR, Stewart R, Krishnan M, Hakim RH. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 24: 919-25. PMID 18840893 DOI: 10.1093/ndt/gfn543  0.055
2015 Brunelli SM, Dluzniewski PJ, Cooper K, Do TP, Sibbel S, Bradbury BD. Management of serum calcium reductions among patients on hemodialysis following cinacalcet initiation. Pharmacoepidemiology and Drug Safety. 24: 1058-67. PMID 26238994 DOI: 10.1002/pds.3845  0.052
2013 Yabu JM, Anderson MW, Kim D, Bradbury BD, Lou CD, Petersen J, Rossert J, Chertow GM, Tyan DB. Sensitization from transfusion in patients awaiting primary kidney transplant. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 28: 2908-18. PMID 24009295 DOI: 10.1093/ndt/gft362  0.051
2013 Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL. Response to High rates of death and hospitalization follow bone fracture among hemodialysis patients. Kidney International. 85: 166-173. PMID 25152548 DOI: 10.1038/ki.2013.279.  0.039
2008 Critchlow CW, Bradbury BD, Acquavella JF, Ruixo JJ, Krishnan M, Chow AT, Brenner RM. The effect of epoetin dose on hematocrit. Kidney International. 74: 827; author reply 82. PMID 18756304 DOI: 10.1038/ki.2008.281  0.024
2008 Bradbury BD, Wang O, Critchlow CW, Rothman KJ, Heagerty P, Keen M, Acquavella JF. In Reply American Journal of Kidney Diseases. 51: 867. DOI: 10.1053/j.ajkd.2008.03.016  0.01
Hide low-probability matches.